News
£12 million collaboration will tackle age and disability-related mobility problems
UCL will lead a £17 million surgical imaging hub to improve cancer detection and take part in a £12 million collaboration to help solve age and disability-related mobility issues, in a major funding award from the UKRI Engineering and Physical Sciences Research Council (EPSRC).
The UCL Optical and Acoustic Imaging for Surgical and Interventional Sciences (OASIS) Hub will be led by Professor Danail Stoyanov from UCL Computer Science.
The hub will create new imaging capabilities in diagnostic and surgical imaging using light and sound, including low-cost, portable devices to detect the early signs of cancer by listening for soundwaves using optical tools.
Every year around 375,000 people are diagnosed with cancer in the UK and more than 50 per cent will undergo surgical interventions.
But the imaging tools currently used for early detection and to aid surgery cannot always distinguish important details in images.
This means that signs of cancer can be missed in surveillance and diagnosis and, in treatment, an inability to remove all cancerous tissue and a likelihood of a need for further surgery.
OASIS, which has been awarded £11 million from the EPSRC alongside £6.1 million in partner funding, aims to tackle these issues.
Work is due to begin in 2025 with partners at Imperial College London, the University of Cambridge and several NHS Trusts.
Professor Stoyanov said: “New imaging methods with AI-assistance have the potential to transform our ability for early diagnosis and treatment of disease.
“The OASIS hub will advance our foundational understanding of the interaction between light, sound and tissue, and use this to pioneer new devices that help to inform clinical decision-making.
“Partnership across disciplines, institutions and industry underpins our approach and will be key to creating innovative solutions that translate into patient benefits across the NHS and beyond.”
The VIVO Hub for Enhanced Independent Living will develop technology, such as robotic clothing that ‘puts itself on and takes itself off’, and wearable devices to prevent falls.
It aims to address the needs of some of the UK’s 6.7 million people with age or disability-related mobility issues.
Working with the NHS, charities, care providers and industrial partners, the healthcare technologies it develops aim to restore the independence of older people and people with disabilities by developing in-home, on-body physical assistance devices to enhance their lives.
VIVO will be led by the University of Bristol in collaboration with UCL, the University of the West of England, Imperial College London and the University of Strathclyde.
It has been awarded £11 million from the EPSRC and £847,000 in partner funding.
Professor Wenhui Song, Head of the UCL Centre for Biomaterials in Surgical Reconstruction and Regeneration at the Royal Free Campus, said: “We are thrilled that this award will enable us to continue designing and synthesizing advanced smart materials and intelligent sensors.
“Those flexible, smart fibres and sensors will be integrated into robotic systems to assist independent living and enhance quality of life for our growing aging population.”
VIVO will involve researchers from UCL Surgery & Interventional Science in the Faculty of Medical Sciences, including Professor Janice Tsui, and from The Ear Institute in the Faculty of Brain Sciences, including Professor Martin Birchall.
UK Science Minister, Lord Vallance, said: “These innovative technologies have the potential to improve patient care in the UK and around the world. By investing in this research, we are enabling scientists to develop life-changing technologies.
“By working closely with patients, healthcare professionals, engineers and industry partners, these advances can be translated into practical solutions that will improve the lives of people with age-related mobility issues, cancer, and other chronic conditions.
The new initiatives are two of five new research projects that aim to transform healthcare through the development and application of revolutionary new technologies, supported by a £118 million investment, including £54 million from the EPSRC.
EPSRC Executive Chair Professor Charlotte Deane said: “The five new hubs bring together a wealth of expertise from across academia, industry and charities to improve population health, transform disease prediction and diagnosis and accelerate the development of new interventions.
“They represent an exciting range of adventurous techniques and approaches that have great potential to improving the lives of millions of people here in the UK and across the world.”
Gut-friendly foods such as kimchi and kombucha may carry hidden risks for heart health when eaten in excess, the British Heart Foundation (BHF) has warned.
The charity said foods marketed as prebiotic, probiotic or otherwise good for the gut can support the microbiome, but some may also be high in salt or sugar, which can raise the risk of cardiovascular disease.
Products highlighted by the British Heart Foundation included kimchi, kombucha, fruit yoghurts, smoothies and sauerkraut. It said there is no harm in including them as part of a healthy diet, but advised people to check labels for added salt and sugar and eat them in moderation.
Tracy Parker, the charity’s nutrition lead, said: “We encourage everyone to choose foods that can keep their gut microbiome healthy. The benefits are clear, and we are continuing to improve our understanding of how a gut-friendly diet may help our hearts.
“A lot of these products can contain high levels of salt or sugar though, so it is important to be aware of the potential drawbacks.
“By ensuring you check package labels for added salt and sugars, and eat each in moderation, you can make sure the risks do not outweigh the benefits for your heart health.”
Fermented foods such as kimchi and sauerkraut are rich in probiotics, the healthy bacteria produced during fermentation that can help support a diverse and healthy gut microbiome.
However, both are traditionally made using a lot of salt, which can raise blood pressure if eaten frequently or in large quantities. High blood pressure is known to increase the risk of heart attack and stroke.
Kombucha, a fermented tea, also contains probiotics and can be a healthier alternative to fizzy drinks, but many commercial and shop-bought versions contain added sugar.
Eating too much sugar can lead to weight gain, which can increase the risk of heart attack, stroke and other cardiovascular disease.
Fruit yoghurts can contain probiotic live bacteria cultures, but may also be high in sugar and have fewer live cultures than plain versions.
The charity said plain yoghurt with live and active cultures on the label can be a lower-sugar option, with whole fruit added at home for sweetness.
Smoothies made with whole fruits provide prebiotic fibre, which feeds beneficial gut bacteria and supports digestive health.
They can also provide vitamins and antioxidants, especially when made with a variety of plant-based ingredients.
But blending breaks down the structure of fruit, releasing free sugars that behave like added sugars in the body and can cause faster rises in blood sugar levels.
Regularly consuming too much sugar can lead to weight gain, which can increase the risk of developing type 2 diabetes, heart disease and kidney disease.
The charity said only one 150ml serving of any smoothie counts towards five-a-day, and suggested adding nuts or seeds for extra protein and fibre to help keep blood sugar levels more stable.
The BHF also noted that some shop-bought sauerkraut is pasteurised, which removes most of the live bacteria.
It advised checking the label, eating small portions and choosing unpasteurised products for those seeking the probiotic benefits.
The charity said beneficial gut bacteria produce short-chain fatty acids during digestion, which are linked to reduced inflammation, better metabolism and better heart and circulatory health.
These good bacteria also help digest polyphenols, natural plant chemicals thought to have antioxidant properties and which may help lower blood pressure.
By contrast, harmful gut bacteria, which thrive on diets high in fat and red meat, produce chemicals that can cause problems in the heart and blood vessels by increasing inflammation and altering how cholesterol is processed in the body.
Beneficial bacteria thrive on varied diets high in prebiotics, non-digestible fibres found in foods such as wholegrains, oats, beans, lentils, bananas and onions.
People with diabetes may have undiagnosed heart failure that could be detected by a simple screening blood test, research suggests.
The TARTAN-HF trial found that one in four patients with diabetes who had at least one other risk factor for heart failure had undiagnosed heart failure detected through screening with a blood test and ultrasound scanning of the heart.
Experts said the findings show the extent of unrecognised heart failure in people with diabetes, and how the condition can be detected using a widely available blood test called NT-proBNP, which measures how much strain the heart is under.
They suggest a heart failure screening programme for diabetics could improve diagnosis rates, lead to earlier treatment and potentially reduce the risk of hospitalisation and death.
The study, involving 700 patients, was led by the University of Glasgow in collaboration with AstraZeneca, Roche Diagnostics, Us2.ai, NHS Greater Glasgow and Clyde and NHS Lanarkshire.
Dr Kieran Docherty, clinical senior lecturer at the University of Glasgow’s School of Cardiovascular and Metabolic Health, said: “Our results from the landmark TARTAN-HF trial identified heart failure in a large proportion of people living with diabetes, emphasising the need for a heart failure screening strategy in this group of patients.
“We know that many of the symptoms and signs of heart failure are non-specific, and may go unrecognised as potentially being due to heart failure for a long time.
“The strategy used in our trial is simple and easy to implement in clinical practice, and will aid in the early identification of heart failure in people with diabetes, and facilitate the initiation of medications that we know improve outcomes in patients with heart failure.”
The study, which began more than three years ago, involved more than 700 people with diabetes from the two health board areas who had at least one other risk factor for heart failure.
They were randomly assigned either to receive heart failure screening or to continue with their usual care.
Researchers found screening uncovered a large number of previously unrecognised cases of heart failure. Around one in four, or 24.9 per cent, of those screened were found to have the condition within six months, compared with 1 per cent in the group continuing their usual care.
The study, involving patients with type 1 and type 2 diabetes, found almost all of the participants found to have heart failure had preserved ejection fraction, which can be difficult to detect without dedicated testing.
The findings of the TARTAN-HF trial were presented at the American College of Cardiology conference taking place from 28 to 30 March in New Orleans in the US.
Dr Edward Piper, medical director at AstraZeneca UK, said: “Delayed diagnosis and treatment of heart failure in people with type 2 diabetes contributes to poor long-term outcomes. TARTAN-HF demonstrates that targeted, risk-based screening can identify previously undiagnosed heart failure in approximately one in four high-risk patients with diabetes, enabling earlier intervention with guideline-directed therapy.”
Dr Christian Simon, head of global medical affairs at Roche Diagnostics, said: “We are proud to have supported the landmark TARTAN-HF trial. These findings demonstrate the transformative power of early, accessible diagnostics like the NT-proBNP blood test.
“By identifying unrecognised heart failure in people with diabetes, we enable clinicians to initiate appropriate treatments sooner, ultimately improving patient outcomes and lives.”
The UK has launched a £6.3m men’s health fund to back local projects aimed at helping men and boys live longer, healthier lives.
The Men’s Health Community Fund is a partnership between the Department of Health and Social Care, Movember and People’s Health Trust.
The government is contributing £3m, while the two charities are more than doubling that to take the total to £6.3m.
Grants will support community projects reaching underserved men and boys aged 16 and over, particularly in the most disadvantaged areas and at key points in their lives such as becoming a father, losing a job or retiring.
Projects could include support for new fathers, activities for men facing loneliness and social isolation, services to help young men engage with the health system, and support for men in work, out of work and moving into retirement.
The programme will bring together voluntary, community and social enterprise organisations to test new ways of reaching men who are least likely to use traditional health services.
An evaluation funded through the National Institute for Health and Care Research will assess what works and help inform future policy and delivery.
Health and social care secretary Wes Streeting said: “Too many men across the country are living shorter, less healthy lives, particularly those in our most disadvantaged communities.
“This new partnership will help men get the support they need in the places they feel most comfortable, their communities, among people they trust.
“By working with expert charities and local organisations, we can reach the men who are too often missed by traditional services and help them take better care of their mental and physical health.”
“It is a key step in delivering our first ever Men’s Health Strategy and driving forward our ambition to halve the gap in healthy life expectancy between the richest and poorest areas.”
The Men’s Health Strategy sets out plans to tackle the physical and mental health challenges men and boys face.
Men can be less likely to seek help and more likely to suffer in silence, while higher rates of smoking, drinking, gambling and drug use are damaging men’s health and affecting families, workplaces and communities.
The government is also investing £3.6m over the next three years in suicide prevention projects for middle-aged men in local communities across areas of England where men are most at risk, many of which are also among the most deprived. Suicide is one of the biggest killers of men under 50, and three-quarters of all suicides are men.
The projects will aim to break down barriers middle-aged men face in seeking support, including stigma around asking for help and a lack of awareness of what is available and how to access it.
They will be co-designed with experts and men with lived experience of mental health crises and suicidal thoughts.
Gut-friendly foods may damage heart, charity warns
Diabetes patients face increased risk of undiagnosed heart failure
UK government announces £6.3m fund to boost men’s health
Brain health collaboratory launches in Gulf South
Centenarian study probes healthy ageing
Centenarian study probes healthy ageing
Active sitting linked to lower dementia risk
Endogenex raises US$50m for diabetes procedure
Working nights undermines type 2 diabetes management – study
UK government announces £6.3m fund to boost men’s health
News4 weeks agoCentenarian study probes healthy ageing
- News4 weeks ago
Active sitting linked to lower dementia risk
- News4 weeks ago
Endogenex raises US$50m for diabetes procedure
- News4 weeks ago
Working nights undermines type 2 diabetes management – study
- News4 weeks ago
UK government announces £6.3m fund to boost men’s health
- News4 weeks ago
Brain health collaboratory launches in Gulf South
- Wellness4 weeks ago
Social isolation is a horrible consequence of dementia – AI could be an answer
- News3 weeks ago
Diabetes patients face increased risk of undiagnosed heart failure
